It’s only fair to share… PF-610355 Molecular Formula C34H39N3O6S Average mass 617.755 Da PF 610655, PF-00610355; PF-610,355 2-[3-[2-[[(2R)-2-hydroxy-2-[4-hydroxy-3-(methylsulfonylamino)phenyl]ethyl]amino]-2-methyl-propyl]phenyl]-N-[[3-(4-hydroxyphenyl)phenyl]methyl]ethanamide 862541-45-5 cas Originator Pfizer Class Antiasthmatics; Benzeneacetamides; Sulfonamides Mechanism of Action Beta 2 adrenergic receptor agonists Orphan Drug StatusNo On Fast trackNo Highest Development Phases Discontinued Asthma; Chronic obstructive pulmonary disease Most Recent Events 11 Aug 2011 Discontinued – Phase-I for Asthma in Belgium (Inhalation) …